Economics of chronic heart failure

Berry, C. , Murdoch, D. R. and McMurray, J. J.V. (2001) Economics of chronic heart failure. European Journal of Heart Failure, 3(3), pp. 283-291. (doi:10.1016/S1388-9842(01)00123-4) (PMID:11377998)

Full text not currently available from Enlighten.


Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1–2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both direct and indirect costs of care. Healthcare expenditure on CHF in developed countries consumes 1–2% of the total health care budget. The cost of hospitalization represents the greatest proportion of total expenditure. Optimization of drug therapy represents the most effective way of reducing costs. Recent economic analyses in the Netherlands and Sweden suggest the costs of care are rising.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Berry, Professor Colin and Murdoch, Dr David and McMurray, Professor John
Authors: Berry, C., Murdoch, D. R., and McMurray, J. J.V.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Journal of Heart Failure
ISSN (Online):1879-0844

University Staff: Request a correction | Enlighten Editors: Update this record